Botanical species · safety record

Ornithogalum thyrsoides

The EFSA Compendium of Botanicals holds 19 constituent measurements and 1 adverse-effect record for Ornithogalum thyrsoides. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ornithogalum thyrsoides Jacq.

19Constituent measurements
1Safety records
4Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Gibberellic acid15
  • Saponins2
  • Steroidal spirostane saponins2

Plant parts

  • Flowering top15
  • Bulb3
  • clove3
  • Flower1
  • Unspecified1

Preparations

  • Solvent extraction19

Effect types

  • Digestive1

Target tissues

  • Digestive1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
SaponinsBulb / cloveSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Steroidal spirostane saponinsBulb / cloveSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Steroidal spirostane saponinsBulb / cloveSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Gibberellic acidFlowering topSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Gibberellic acidFlowering topSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Gibberellic acidFlowering topSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Gibberellic acidFlowering topSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Gibberellic acidFlowering topSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Gibberellic acidFlowering topSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Gibberellic acidFlowering topSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Gibberellic acidFlowering topSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Gibberellic acidFlowering topSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Gibberellic acidFlowering topSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Gibberellic acidFlowering topSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Gibberellic acidFlowering topSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Gibberellic acidFlowering topSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Gibberellic acidFlowering topSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Gibberellic acidFlowering topSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
SaponinsUnspecifiedSolvent extractionUnspecifiedNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestiveFlowerHorse (as animal)Case reportNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Koshioka, M., Roh, M., Nakayama, M., Hisamatsu, T., Mander, LN. Identification of endogenous gibberellins in inflorescence of Ornithogalum thyrsoides. JOURNAL OF THE JAPANESE SOCIETY FOR HORTICULTURAL SCIENCE, 1999, vol. 68, no. 6, p. 1158-1160.
  2. Botha, CJ., Naude, TW. Plant poisonings and mycotoxicoses of importance in horses in southern Africa . Journal of the south african veterinary association-tydskrif van die suid-afrikaanse veterinere vereniging, 2002, vol. 73, no. 3, p. 91-97.
  3. Kuroda, M., Mimaki, Y., Ori, K., Sakagami, H., Sashida, Y. Steroidal glycosides from the bulbs of Ornithogalum thyrsoides. JOURNAL OF NATURAL PRODUCTS, 2004, vol. 67, no. 10, p. 1690-1696. DOI
  4. Kuroda, M., Ori, K., Mimaki, Y. Ornithosaponins A-D, four new polyoxygenated steroidal glycosides from the bulbs of Ornithogalum thyrsoides. STEROIDS, 2006, vol. 71, no. 3, p. 199-205. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue